{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:27:22Z","timestamp":1782257242865,"version":"3.54.5"},"reference-count":40,"publisher":"China Science Publishing & Media Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400611"],"award-info":[{"award-number":["81400611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation of Shanghai Tongren Hospital","award":["TR201413"],"award-info":[{"award-number":["TR201413"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/abbs\/gmx017","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T20:24:05Z","timestamp":1489695845000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":61,"title":["MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1"],"prefix":"10.3724","volume":"49","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"Torre LA","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65: 87-108.","journal-title":"CA Cancer J Clin"},{"key":"null","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/ars.2008.2095","volume":"11","author":"Kuo MT","year":"2009","unstructured":"Kuo MT. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal, 2009, 11: 99-133.","journal-title":"Antioxid Redox Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"Forner A","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet, 2012, 379: 1245-1255.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"Filipowicz W","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight. Nat Rev Genet, 2008, 9: 102-114.","journal-title":"Nat Rev Genet"},{"key":"null","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/hep.28821","volume":"64","author":"Chai S","year":"2016","unstructured":"Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, Yuan YF. Octamer 4\/microRNA-1246 signaling axis drives Wnt\/beta-catenin activation in liver cancer stem cells. Hepatology, 2016, 64: 2062-2076.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","unstructured":"Couchy G, Roskams T, Govaere O, Oren M, Giladi H, Galun E . The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53\/mouse double minute 2 homolog circuitry. Hepatology 2016, 64: 1623\u20131636.","DOI":"10.1002\/hep.28679"},{"key":"null","first-page":"529","volume":"65","author":"Ma JZ","year":"2016","unstructured":"Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Wang TT. METTL14 suppresses the metastatic potential of HCC by modulating m6 A-dependent primary miRNA processing. Hepatology, 2016, 65: 529-543.","journal-title":"Hepatology"},{"key":"null","first-page":"1113","volume":"84","author":"Ma S","year":"2016","unstructured":"Ma S, Chen L, Luo L, Chen W, Xu HX, Chen F, Chen LZ. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53. Hepatology, 2016, 84: 1113-1118.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.28679","volume":"64","author":"Simerzin A","year":"2016","unstructured":"Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53\/mouse double minute 2 homolog circuitry. Hepatology, 2016, 64: 1623-1636.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-016-0296-0","volume":"35","author":"Liu Y","year":"2016","unstructured":"Liu Y, Li Y, Wang R, Qin S, Liu J, Su F, Yang Y. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. J Exp Clin Cancer Res, 2016, 35:","journal-title":"J Exp Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yexcr.2017.01.022","author":"Chen J","year":"2017","unstructured":"Chen J, Zhang H, Chen Y, Qiao G, Jiang W, Ni P, Liu X. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1\/Notch2 pathway stimulating EMT. Exp Cell Res, 2017, 104-112.","journal-title":"Exp Cell Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12985-017-0695-7","volume":"14","author":"Xia YF","year":"2017","unstructured":"Xia YF, Pei GH, Wang N, Che YC, Yu FS, Yin FF, Liu HX. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Virol J, 2017, 14:","journal-title":"Virol J"},{"key":"null","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12918-016-0357-1","volume":"10","author":"Zhang S","year":"2016","unstructured":"Zhang S, Ng MK. Gene-microRNA network module analysis for ovarian cancer. BMC Syst Biol, 2016, 10:","journal-title":"BMC Syst Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jgg.2016.10.005","volume":"44","author":"Zhao Z","year":"2017","unstructured":"Zhao Z, Fan X, Jiang L, Xu Z, Xue L, Zhan Q, Song Y. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin. J Genet Genomics, 2017, 44: 75-84.","journal-title":"J Genet Genomics"},{"key":"null","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-017-0591-1","volume":"16","author":"Zhu J","year":"2017","unstructured":"Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D. CD73\/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer, 2017, 16:","journal-title":"Mol Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"53443","DOI":"10.18632\/oncotarget.10803","volume":"7","author":"Ilm K","year":"2016","unstructured":"Ilm K, Fuchs S, Mudduluru G, Stein U. MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer. Oncotarget, 2016, 7: 53443-53458.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3727\/096504016X14738114257367","volume":"25","author":"Wang G","year":"2017","unstructured":"Wang G, Fu Y, Liu G, Ye Y, Zhang X. miR-218 inhibits proliferation, migration, and EMT of gastric cancer cells by targeting WASF3. Oncol Res, 2017, 25: 355-364.","journal-title":"Oncol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"15241","DOI":"10.1007\/s13277-016-5388-0","volume":"37","author":"Wang LL","year":"2016","unstructured":"Wang LL, Wang L, Wang XY, Shang D, Yin SJ, Sun LL, Ji HB. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Tumour Biol, 2016, 37: 15241-15252.","journal-title":"Tumour Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3892\/mmr.2015.3516","volume":"12","author":"Dong Y","year":"2015","unstructured":"Dong Y, Zou J, Su S, Huang H, Deng Y, Wang B, Li W. MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma. Mol Med Rep, 2015, 12: 1016-1022.","journal-title":"Mol Med Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2015.05.016","volume":"63","author":"Fu WM","year":"2015","unstructured":"Fu WM, Zhu X, Wang WM, Lu YF, Hu BG, Wang H, Liang WC. Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling. J Hepatol, 2015, 63: 886-895.","journal-title":"J Hepatol"},{"key":"null","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12094-015-1447-z","volume":"18","author":"Yang L","year":"2016","unstructured":"Yang L, Xu Q, Xie H, Gu G, Jiang J. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Clin Transl Oncol, 2016, 18: 841-847.","journal-title":"Clin Transl Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.7314\/APJCP.2013.14.6.3681","volume":"14","author":"Jin J","year":"2013","unstructured":"Jin J, Cai L, Liu ZM, Zhou XS. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev, 2013, 14: 3681-3684.","journal-title":"Asian Pac J Cancer Prev"},{"key":"null","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3892\/ol.2015.3068","volume":"9","author":"Jun GJ","year":"2015","unstructured":"Jun GJ, Zhong GG, Ming ZS. miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6\/cyclin D1\/p21Cip1\/Waf1 pathway. Oncol Lett, 2015, 9: 2743-2749.","journal-title":"Oncol Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"16372","DOI":"10.4238\/2015.December.9.5","volume":"14","author":"Li BS","year":"2015","unstructured":"Li BS, Liu H, Yang WL. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis. Genet Mol Res, 2015, 14: 16372-16378.","journal-title":"Genet Mol Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1038\/cddis.2014.541","volume":"6","author":"Ma MZ","year":"2015","unstructured":"Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, Quan ZW. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis, 2015, 6:","journal-title":"Cell Death Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/cas.12441","volume":"105","author":"Nishikawa R","year":"2014","unstructured":"Nishikawa R, Goto Y, Sakamoto S, Chiyomaru T, Enokida H, Kojima S, Kinoshita T. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Sci, 2014, 105: 802-811.","journal-title":"Cancer Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3892\/etm.2015.2455","volume":"10","author":"Tang BB","year":"2015","unstructured":"Tang BB, Liu SY, Zhan YU, Wei LQ, Mao XL, Wang J, Li LI. microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer. Exp Ther Med, 2015, 10: 269-274.","journal-title":"Exp Ther Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.msec.2016.10.052","volume":"72","author":"Tu L","year":"2017","unstructured":"Tu L, Wang M, Zhao WY, Zhang ZZ, Tang DF, Zhang YQ, Cao H. miRNA-218-loaded carboxymethyl chitosan\u2014tocopherol nanoparticle to suppress the proliferation of gastrointestinal stromal tumor growth. Mater Sci Eng C Mater Biol Appl, 2017, 72: 177-184.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"null","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biopha.2012.04.006","volume":"66","author":"Yang L","year":"2012","unstructured":"Yang L, Li Q, Wang Q, Jiang Z, Zhang L. Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway. Biomed Pharmacother, 2012, 66: 535-540.","journal-title":"Biomed Pharmacother"},{"key":"null","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/abbs\/gmt109","volume":"45","author":"Zhang C","year":"2013","unstructured":"Zhang C, Ge S, Hu C, Yang N, Zhang J. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. Acta Biochim Biophys Sin, 2013, 45: 1055-1061.","journal-title":"Acta Biochim Biophys Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"80751","DOI":"10.18632\/oncotarget.13037","volume":"7","author":"Chen M","year":"2016","unstructured":"Chen M, Hu W, Xiong CL, Qu Z, Yin CQ, Wang YH, Luo CL. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival. Oncotarget, 2016, 7: 80751-80764.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2016.10.035","volume":"385","author":"Peng Y","year":"2016","unstructured":"Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao Y, Cheng Y. MiRNA-194 activates the Wnt\/beta-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU. Cancer Lett, 2016, 385: 117-127.","journal-title":"Cancer Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trsl.2016.10.001","volume":"181","author":"Weng M","year":"2017","unstructured":"Weng M, Wu D, Yang C, Peng H, Wang G, Wang T, Li X. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Transl Res, 2017, 181: 108-120.","journal-title":"Transl Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"45622","DOI":"10.18632\/oncotarget.9850","volume":"7","author":"Jiang Z","year":"2016","unstructured":"Jiang Z, Song Q, Zeng R, Li J, Li J, Lin X, Cheng X. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer. Oncotarget, 2016, 7: 45622-45636.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3892\/mmr.2016.5403","volume":"14","author":"Wang J","year":"2016","unstructured":"Wang J, Ying Y, Bo S, Li G, Yuan F. Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9. Mol Med Rep, 2016, 14: 1829-1834.","journal-title":"Mol Med Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.taap.2016.05.012","volume":"304","author":"Lu L","year":"2016","unstructured":"Lu L, Xu H, Luo F, Liu X, Lu X, Yang Q, Xue J. Epigenetic silencing of miR-218 by the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle transition in the malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Appl Pharmacol, 2016, 304: 30-41.","journal-title":"Toxicol Appl Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/jcm4081651","volume":"4","author":"Ohtsuka M","year":"2015","unstructured":"Ohtsuka M, Ling H, Doki Y, Mori M, Calin GA. MicroRNA processing and human cancer. J Clin Med, 2015, 4: 1651-1667.","journal-title":"J Clin Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2007.06.023","volume":"107","author":"Koensgen D","year":"2007","unstructured":"Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. Gynecol Oncol, 2007, 107: 266-273.","journal-title":"Gynecol Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/1471-2407-12-597","volume":"12","author":"Serce NB","year":"2012","unstructured":"Serce NB, Boesl A, Klaman I, von Serenyi S, Noetzel E, Press MF, Dimmler A. Overexpression of SERBP1 (plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis. BMC Cancer, 2012, 12:","journal-title":"BMC Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1007\/s13277-016-5158-z","volume":"37","author":"Guo K","year":"2016","unstructured":"Guo K, Zheng S, Xu Y, Xu A, Chen B, Wen Y. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. Tumour Biol, 2016, 37: 12843-12854.","journal-title":"Tumour Biol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/BA5A24B8CA4D4BAF83CFB91130E444FD","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmx017","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/BA5A24B8CA4D4BAF83CFB91130E444FD","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:36:28Z","timestamp":1692725788000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmx017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,1]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmx017","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,1]]}}}